The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
How do immune cells overcome the blood-brain barrier in multiple sclerosis?
Open accessAbstract
The presence of the blood-brain barrier (BBB) restricts the movement of soluble mediators and leukocytes from the periphery to the central nervous system (CNS). Leukocyte entry into the CNS is nonetheless an early event in multiple sclerosis (MS), an inflammatory disorder of the CNS. Whether BBB dysfunction precedes immune cell infiltration or is the consequence of perivascular leukocyte accumulation remains enigmatic, but leukocyte migration modifies BBB permeability. Immune cells of MS subjects express inflammatory cytokines, reactive oxygen species (ROS) and enzymes that can facilitate their migration to the CNS by influencing BBB function, either directly or indirectly. In this review, we describe how immune cells from the peripheral blood overcome the BBB and promote CNS inflammation in MS through BBB disruption.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies showed that systemic inflammation contributes to the disease progression and the activation of immune cells allows the infiltration of T and B cells into the CNS, promoting the release of chemokines that in turn stimulate the migration of more immune cells, leading to BBB disruption (Holman et al., 2011; Kooij et al., 2011; Larochelle et al., 2011; Willis, 2011).”
From The impact of microglial activation on blood-brain barrier in brain diseases (2014) · cites this paper as Larochelle et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Polman, C. H., O'Connor, P. W., Havrdová, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., LUBLIN, F. D., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,433
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Kappos, L., Radue, E. W., O'Connor, P. W., Polman, C. H., Hohlfeld, R., Calabresi, P. A., Selmaj, K. W., Agoropoulou, C., Leyk, M., Zhang-Auberson, L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909494 · Cited by 2,670
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN
Brightman, M., & Reese, T. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.40.3.648 · Cited by 2,457
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Cohen, J. A., Barkhof, F., Comı, G., Hartung, H., Khatri, B. O., Montalbán, X., Pelletier, J., Capra, R., Gallo, P., Izquierdo, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907839 · Cited by 2,220
Pericytes are required for blood–brain barrier integrity during embryogenesis
Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jäger, A., Strom, T. B., Oukka, M., & Kuchroo, V. K. (2007) · Nature · doi:10.1038/nature05970 · Cited by 1,896
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759
Self-citation(1991) · Medical Entomology and Zoology · Cited by 1,512
Essential autocrine regulation by IL-21 in the generation of inflammatory T cells
Nurieva, R., Yang, X. O., Martinez, G., Zhang, Y., Panopoulos, A. D., Ma, L., Schluns, K., Tian, Q., Watowich, S. S., Jetten, A. M., et al. (2007) · Nature · doi:10.1038/nature05969 · Cited by 1,466
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Ghoreschi, K., Laurence, A., Yang, X.-P., Tato, C. M., McGeachy, M. J., Konkel, J. E., Ramos, H. L., Wei, L., Davidson, T. S., Bouladoux, N., et al. (2010) · Nature · doi:10.1038/nature09447 · Cited by 1,388
Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J. A., Newcombe, J., Esiri, M. M., & Fugger, L. H. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,225
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,068
Three or more routes for leukocyte migration into the central nervous system
Ransohoff, R. M., Kivisäkk, P., & Kidd, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1130 · Cited by 1,052
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
Giovannoni, G., Comı, G., Cook, S. D., Rammohan, K. W., Rieckmann, P., Sørensen, P. S., Vermersch, P., Chang, P., Hamlett, A., Musch, B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0902533 · Cited by 1,021
IL-21 and TGF-β are required for differentiation of human TH17 cells
Yang, L., Anderson, D. E., Baecher‐Allan, C., Hastings, W. D., Bettelli, E., Oukka, M., Kuchroo, V. K., & Hafler, D. A. (2008) · Nature · doi:10.1038/nature07021 · Cited by 951
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
Dutta, R., McDonough, J., Yin, X., Peterson, J. W., Chang, A., Torres, T., Gudz, T. I., Macklin, W. B., Lewis, D., Fox, R., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20736 · Cited by 881
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
Matusevičius, D., Kivisäkk, P., He, B., Kostulas, N., Özenci, V., Fredrikson, S., & Link, H. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500206 · Cited by 751
Prolonged activation of jun and collagenase genes by tumour necrosis factor-α
Brenner, D. A., O'Hara, M., Angel, P. E., Chojkier, M., & Karin, M. (1989) · Nature · doi:10.1038/337661a0 · Cited by 709
VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown
Argaw, A. T., Gurfein, B. T., Zhang, Y., Zameer, A., & John, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808698106 · Cited by 666
Oldendorf, W. H., Cornford, M. E., & Brown, W. J. (1977) · Annals of Neurology · doi:10.1002/ana.410010502 · Cited by 651
Kivisäkk, P., Mahad, D., Callahan, M. K., Trebst, C., Tucky, B. H., Wei, T., Wu, L., Bækkevold, E. S., Lassmann, H., Staugaitis, S. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1433000100 · Cited by 571
Agrawal, S., Anderson, P., Durbeej, M., van Rooijen, N., Ivars, F., Opdenakker, G., & Sorokin, L. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051342 · Cited by 559
Tight Junctions of the Blood–Brain Barrier
Kniesel, U., & Wolburg, H. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006995910836 · Cited by 535
Cellular mechanisms of IL-17-induced blood-brain barrier disruption
Huppert, J., Closhen, D., Croxford, A., White, R., Kulig, P., Pietrowski, E., Bechmann, I., Becher, B., Luhmann, H. J., Waisman, A., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-141978 · Cited by 529
What is the blood–brain barrier (not)?
Bechmann, I., Galea, I., & Perry, V. H. (2007) · Trends in Immunology · doi:10.1016/j.it.2006.11.007 · Cited by 520
Sixt, M., Engelhardt, B., Pausch, F., Hallmann, R., Wendler, O., & Sorokin, L. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.933 · Cited by 504
Basic principles of immunological surveillance of the normal central nervous system
Hickey, W. F. (2001) · Glia · doi:10.1002/glia.1101 · Cited by 476
SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier
Lee, S., Kim, W. J., Choi, Y. K., Song, H. S., Son, M. J., Gelman, I. H., Kim, Y.-J., & Kim, K. (2003) · Nature Medicine · doi:10.1038/nm889 · Cited by 473
The double-edged role of nitric oxide in brain function and superoxide-mediated injury.
Beckman, J. S. (1991) · PubMed · Cited by 463
Cayrol, R., Wosik, K., Berard, J. L., Dodelet-Devillers, A., Ifergan, I., Kebir, H., Haqqani, A. S., Kreymborg, K., Krug, S., Moumdjian, R., et al. (2008) · Nature Immunology · doi:10.1038/ni1551 · Cited by 444
Self-citationSamoilova, E. B., Horton, J. L., Hilliard, B. A., Liu, T.-S. T., & Chen, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6480 · Cited by 441
T‐helper 17 cells expand in multiple sclerosis and are inhibited by interferon‐β
Durelli, L., Conti, L., Clerico, M., Boselli, D., Contessa, G., Ripellino, P., Ferrero, B., Eid, P., & Novelli, F. (2009) · Annals of Neurology · doi:10.1002/ana.21652 · Cited by 389
Tran, E., Hoekstra, K., van Rooijen, N., Dijkstra, C., & Owens, T. (1998) · Journal of Immunology · doi:10.4049/jimmunol.161.7.3767 · Cited by 373
Perivascular Spaces and the Two Steps to Neuroinflammation
Owens, T., Bechmann, I., & Engelhardt, B. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818f9ca8 · Cited by 368
Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia
Rosenberg, G. A., & Yang, Y. R. (2007) · Neurosurgical FOCUS · doi:10.3171/foc.2007.22.5.5 · Cited by 358
Molecular mechanisms involved in T cell migration across the blood–brain barrier
Engelhardt, B. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0409-y · Cited by 344
The paradox of matrix metalloproteinases in infectious disease
Elkington, P. T., O’Kane, C. M., & Friedland, J. S. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02840.x · Cited by 343
Disruption of central nervous system barriers in multiple sclerosis
Alvarez, J. I., Cayrol, R., & Prat, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.017 · Cited by 334
Self-citationLu, F., Selak, M. A., O'Connor, J. J., Croul, S. E., Lorenzana, C., Butunoi, C., & Kálmán, B. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00343-9 · Cited by 331
Radical changes in multiple sclerosis pathogenesis
van Horssen, J., Witte, M. E., Schreibelt, G., & de Vries, H. E. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.011 · Cited by 325
van Horssen, J., Schreibelt, G., Drexhage, J., Hazes, T., Dijkstra, C. D., van der Valk, P., & de Vries, H. E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.023 · Cited by 321
Kim, S.-R., Bae, Y.-H., Bae, S., Choi, K.-S., Yoon, K., Koo, T. H., Jang, H.-O., Yun, I., Kim, K.-W., Kwon, Y., et al. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.004 · Cited by 314
Wong, D. K., & Dorovini‐Zis, K. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90170-p · Cited by 303
Kang, Z., Altuntas, C. Z., Gulen, M. F., Liu, C., Giltiay, N., Qin, H., Liu, L., Qian, W., Ransohoff, R. M., Bergmann, C., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.004 · Cited by 297
Maeda, A., & Sobel, R. A. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199603000-00005 · Cited by 293
Alcohol-induced oxidative stress in brain endothelial cells causes blood-brain barrier dysfunction
Haorah, J., Knipe, B., Leibhart, J., Ghorpade, A., & Persidsky, Y. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0605340 · Cited by 275
Wu, C., Ivars, F., Anderson, P. O., Hallmann, R., Vestweber, D., Nilsson, P., Robenek, H., Tryggvason, K., Song, J., Korpos, É., et al. (2009) · Nature Medicine · doi:10.1038/nm.1957 · Cited by 264
Wosik, K., Cayrol, R., Dodelet-Devillers, A., Berthelet, F., Bernard, M., Moumdjian, R. A., Bouthillier, A., Reudelhuber, T. L., & Prat, A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2088-07.2007 · Cited by 264
Self-citationProduction and functions of IL-17 in microglia
Kawanokuchi, J., Shimizu, K., Nitta, A., Yamada, K., Mizuno, T., Takeuchi, H., & Suzumura, A. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.006 · Cited by 253
Igarashi, Y., Utsumi, H., Chiba, H., Yamada-Sasamori, Y., Tobioka, H., Kamimura, Y., Furuuchi, K., Kokai, Y., Nakagawa, T., Mori, M., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0992 · Cited by 252
Wagoner, N. J. V., Oh, J., Repovic, P., & Benveniste, E. N. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05236.1999 · Cited by 250
Chui, R. W., & Dorovini‐Zis, K. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-1 · Cited by 249
The blood-brain barrier, chemokines and multiple sclerosis
Holman, D. W., Klein, R. S., & Ransohoff, R. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.019 · Cited by 247
Inflammatory Cell Migration into the Central Nervous System: A Few New Twists on an Old Tale
Man, S., Ubogu, E. E., & Ransohoff, R. M. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00067.x · Cited by 244
Tavares, J. C., Hickey, M. J., Hutchison, J. S., Michaud, J., Sutcliffe, I. T., & Kubes, P. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1141 · Cited by 236
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis
Waubant, E. L., Goodkin, D., Gee, L., Bacchetti, P., Sloan, R., Stewart, T. J., Andersson, P.-B., Stabler, G., & Miller, K. (1999) · Neurology · doi:10.1212/wnl.53.7.1397 · Cited by 234
Raine, C. S., Cannella, B., Duijvestijn, A. M., & Cross, A. H. (1990) · PubMed · Cited by 229
MMPs in the central nervous system: Where the good guys go bad
AGRAWAL, S., LAU, L., & Yong, V. W. (2007) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2007.06.003 · Cited by 226
Expression and regulation of toll-like receptors in cerebral endothelial cells
Nagyőszi, P., Wilhelm, I., Farkas, A. E., Fazakas, C., Dung, N. T. K., Haskó, J., & Krizbai, I. A. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.07.002 · Cited by 203
Peroxynitrite formation within the central nervous system in active multiple sclerosis
Cross, A. H., Manning, P. T., Keeling, R. M., Schmidt, R. E., & Misko, T. P. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00078-2 · Cited by 201
Liu, W., Hendren, J. D., Qin, X., Shen, J., & Liu, K. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05821.x · Cited by 195
Azoulay, D., Vachapova, V., Shihman, B., Miler, A., & Karni, A. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.07.001 · Cited by 193
Hendriks, J. J. A., Alblas, J., van der Pol, S. M. A., van Tol, E. A. F., Dijkstra, C. D., & de Vries, H. E. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040819 · Cited by 191
Al-Ahmad, A. J., Taboada, C. B., Gassmann, M., & Ogunshola, O. O. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.148 · Cited by 183
Reactive oxygen species are required for the phagocytosis of myelin by macrophages
van der Goes, A., Brouwer, J. P., Hoekstra, K., Roos, D., van den Berg, T. K., & Dijkstra, C. D. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00175-1 · Cited by 180
Sarma, J. D., Ćirić, B., Marek, R. A., Sadhukhan, S., Caruso, M., Shafagh, J., Fitzgerald, D. C., Shindler, K. S., & Rostami, A. M. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-14 · Cited by 179
Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia
Li, Y., Chu, N., Hu, A., Gran, B., Rostami, A. M., & ZHANG, G. (2006) · Brain · doi:10.1093/brain/awl273 · Cited by 170
Nishioku, T., Matsumoto, J., Dohgu, S., Sumi, N., Miyao, K., Takata, F., Shuto, H., Yamauchi, A., & Kataoka, Y. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09292sc · Cited by 168
Schreibelt, G., Musters, R. J. P., Reijerkerk, A., de Groot, L. R., van der Pol, S. M. A., van Kesteren-Hendrikx, E. M. L., Döpp, E. A., Dijkstra, C. D., Drukarch, B., & de Vries, H. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2630 · Cited by 167
Structural and Functional Variations in Capillary Systems within the Braina
Fenstermacher, J. D., Gross, P. M., Sposito, N. M., Acuff, V., Pettersen, S. E., & Gruber, K. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb51416.x · Cited by 162
Reactive oxygen species enhance the migration of monocytes across the blood‐brain barrier in vitro
van der Goes, A., Wouters, D., van der Pol, S. M. A., Huizinga, R., Ronken, E., Adamson, P., Greenwood, J., Dijkstra, C. D., & de Vries, H. E. (2001) · The FASEB Journal · doi:10.1096/fj.00-0881fje · Cited by 162
IL-17 Enhancement of the IL-6 Signaling Cascade in Astrocytes
Ma, X., Reynolds, S. L., Baker, B. J., Li, X., Benveniste, E. N., & Qin, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000142 · Cited by 161
Schulze, C., & Firth, J. A. (1993) · Journal of Cell Science · doi:10.1242/jcs.104.3.773 · Cited by 159
Ifergan, I., Wosik, K., Cayrol, R., Kébir, H., Auger, C., Bernard, M., Bouthillier, A., Moumdjian, R. A., Duquette, P., & Prat, A. (2006) · Annals of Neurology · doi:10.1002/ana.20875 · Cited by 158
Self-citationWeaver, A., DaSilva, A. G., Nuttall, R. K., Edwards, D. R., Shapiro, S. D., Rivest, S., & Yong, V. W. (2005) · The FASEB Journal · doi:10.1096/fj.04-2030fje · Cited by 158
IL‐21 and IL‐21R are not required for development of Th17 cells and autoimmunity in vivo
Sonderegger, I., Kisielow, J., Meier, R., King, C., & Köpf, M. (2008) · European Journal of Immunology · doi:10.1002/eji.200838511 · Cited by 155
Role of aquaporin-4 water channel in the development and integrity of the blood-brain barrier
Nico, B., Frigeri, A., Nicchia, G. P., Quondamatteo, F., Herken, R., Errede, M., Ribatti, D., Svelto, M., & Roncali, L. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.7.1297 · Cited by 154
Caruso, R., Fina, D., Peluso, I., Stolfi, C., Fantini, M. C., Gioia, V., Caprioli, F., Blanco, G. D. V., Paoluzi, O. A., MacDonald, T. T., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.053 · Cited by 150
On the mode of entry of blood vessels into the cerebral cortex.
Jones, E. G. (1970) · PubMed · Cited by 146
IL-21 and IL-21 Receptor Expression in Lymphocytes and Neurons in Multiple Sclerosis Brain
Tzartos, J. S., Craner, M. J., Friese, M. A., Jakobsen, K. B., Newcombe, J., Esiri, M. M., & Fugger, L. H. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.10.043 · Cited by 146
Ransohoff, R. M. (2005) · Nature Neuroscience · doi:10.1038/nn1005-1275 · Cited by 141
Reijerkerk, A., Kooij, G., van der Pol, S. M. A., Khazen, S., Dijkstra, C. D., & de Vries, H. E. (2006) · The FASEB Journal · doi:10.1096/fj.06-6099fje · Cited by 140
Differential Effects of IL-21 during Initiation and Progression of Autoimmunity against Neuroantigen
Vollmer, T. L., Liu, R., Price, M. A., Rhodes, S. N., Cava, A. L., & Shi, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2696 · Cited by 137
Potter, S. M., Chan‐Ling, T., Ball, H. J., Mansour, H., Mitchell, A. J., Maluish, L., & Hunt, N. H. (2006) · International Journal for Parasitology · doi:10.1016/j.ijpara.2005.12.005 · Cited by 137
Wong, D. K., & Dorovini‐Zis, K. (1995) · Microvascular Research · doi:10.1006/mvre.1995.1028 · Cited by 137
Ferretti, G., Bacchetti, T., Principi, F., DiLudovico, F., Viti, B., Angeleri, V. A., Danni, M. C., & Provinciali, L. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1240oa · Cited by 136
Overall, C. M., McQuibban, G. A., & Clark‐Lewis, I. (2002) · Biological Chemistry · doi:10.1515/bc.2002.114 · Cited by 133
Regulation of Inflammatory Responses by Oncostatin M
Wallace, P. M., MacMaster, J. F., Rouleau, K. A., Brown, T. J., Loy, J. K., Donaldson, K. L., & Wahl, A. F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5547 · Cited by 129
Huang, W., Huang, P., & Hillert, J. A. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1071oa · Cited by 128
Elevated myeloperoxidase activity in white matter in multiple sclerosis
Gray, E., Thomas, T. L., Betmouni, S., Scolding, N. J., & Love, S. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.08.035 · Cited by 125
Azoulay, D., Urshansky, N., & Karni, A. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.01.010 · Cited by 125
Galboiz, Y., Shapiro, S., Lahat, N., Rawashdeh, H., & Miller, A. (2001) · Annals of Neurology · doi:10.1002/ana.1218 · Cited by 125
Quintana, A., Müller, M., Frausto, R. F., Ramos, R., Getts, D. R., Sanz, E., Hofer, M. J., Krauthausen, M., King, N. J. C., Hidalgo, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900242 · Cited by 121
Hohnoki, K., Inoue, A., & Koh, C. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00053-8 · Cited by 121
Lv, S., Song, H.-L., Zhou, Y., Li, L.-X., Cui, W., Wang, W., & Liu, P. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02211.x · Cited by 120
Zozulya, A. L., Reinke, E. K., Baiu, D. C., Kármán, J., Sándor, M., & Fábry, Z. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.520 · Cited by 118
Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes
Ehrlich, S., Infante‐Duarte, C., Seeger, B., & Zipp, F. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00094-2 · Cited by 116
Characteristic gene expression profile of primary human cerebral endothelial cells
Kallmann, B.-A., Wagner, S., Hummel, V., Buttmann, M., Bayas, A., Tonn, J. C., & Rieckmann, P. (2002) · The FASEB Journal · doi:10.1096/fj.01-0594fje · Cited by 113
Özenci, V., Kouwenhoven, M. C. M., Huang, Y.-M., Kivisäkk, P., & Link, H. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01175.x · Cited by 111
Subileau, E. A., Rezaie, P., Davies, H. A., Colyer, F. M., Greenwood, J., Male, D. K., & Romero, I. A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318197eca7 · Cited by 111
Induction of Blood Brain Barrier Tight Junction Protein Alterations by CD8 T Cells
Suidan, G. L., Mcdole, J. R., Chen, Y., Pirko, I., & Johnson, A. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003037 · Cited by 105
Peroxynitrite-mediated lipid oxidation and nitration: mechanisms and consequences
Rubbo, H., Trostchansky, A., & O’Donnell, V. B. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.11.007 · Cited by 105
Management of worsening multiple sclerosis with mitoxantrone: A review
Fox, E. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.04.013 · Cited by 102
Ruprecht, K., Kuhlmann, T., Seif, F., Hummel, V., Kruse, N., Brück, W., & Rieckmann, P. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.11.1087 · Cited by 102
Lynch, N. J., Willis, C. L., Nolan, C. C., Roscher, S., Fowler, M. J., Weihe, E., Ray, D. E., & Schwaeble, W. (2003) · Molecular Immunology · doi:10.1016/j.molimm.2003.08.009 · Cited by 100
Upregulation of vascular growth factors in multiple sclerosis: Correlation with MRI findings
Su, J.-J., Osoegawa, M., Matsuoka, T., Minohara, M., Tanaka, M., Ishizu, T., Mihara, F., Taniwaki, T., & Kira, J. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.11.006 · Cited by 98
Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis
Jadidi‐Niaragh, F., & Mirshafiey, A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.05.005 · Cited by 97
Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis
Greco, A., Minghetti, L., Sette, G., Fieschi, C., & Levi, G. (1999) · Neurology · doi:10.1212/wnl.53.8.1876 · Cited by 97
Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes
Trajković, V., Stošić‐Grujičić, S., Samardžić, T., Marković, M., Miljković, D. M., Ramić, Z., & Stojković, M. M. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00391-5 · Cited by 97
Brain Pericytes: Emerging Concepts and Functional Roles in Brain Homeostasis
Kamouchi, M., Ago, T., & Kitazono, T. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9605-x · Cited by 96
Moser, K. V., Reindl, M., Blasig, I. E., & Humpel, C. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.013 · Cited by 95
Lichtinghagen, R., Seifert‐Held, T., Kracke, A., Marckmann, S., Wurster, U., & Heidenreich, F. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00094-6 · Cited by 95
Navikas, V., He, B., Link, J., Haglund, M., Söderström, M. B., Fredrikson, S., Ljungdahl, Å., Höjeberg, B., Qiao, J., Olsson, T. P., et al. (1996) · Brain · doi:10.1093/brain/119.1.213 · Cited by 90
Wong, D., Prameya, R., & Dorovini-Zis, K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.12.003 · Cited by 88
Navikas, V., Matusevicius, D., Söderström, M., Fredrikson, S., Kivisäkk, P., Ljungdahl, Å., Hojeberg, B., & Link, H. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00155-7 · Cited by 88
Graesser, D., Mahooti, S., & Madri, J. A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00275-7 · Cited by 88
Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors
Mrass, P., & Weninger, W. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00433.x · Cited by 87
Quandt, J. A., & Dorovini‐Zis, K. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.4.350 · Cited by 87
Regulation and Functional Effects of Monocyte Migration across Human Brain-Derived Endothelial Cells
Seguin, R. M., Biernacki, K., Rotondo, R. L., Prat, A., & Antel, J. P. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.412 · Cited by 86
Self-citationSithu, S. D., English, W., Olson, P. R., Krubasik, D., Baker, A. H., Murphy, G., & D’Souza, S. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611273200 · Cited by 85
Agrawal, S. M., Silva, C., Tourtellotte, W., & Yong, W. V. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3659-10.2011 · Cited by 84
OR.41. IL-21 and TGF-β are Required for Differentiation of Human Th17 Cells
Anderson, D., Yang, L., Baecher‐Allan, C., Bettelli, E., Oukka, M., Kuchroo, V. K., & Hafler, D. A. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.03.047 · Cited by 83
The many faces of EMMPRIN—Roles in neuroinflammation
Agrawal, S. M., & Yong, V. W. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.018 · Cited by 82
Kim, H. S., Cho, I. H., Kim, J., Shin, Y. J., Jeon, J., Kim, Y., Yang, Y. M., Lee, K. H., Lee, S. E., Lee, W.-J., et al. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.06.009 · Cited by 79
Unemori, E., Bair, M. J., Bauer, E. A., & Amento, E. P. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54522-1 · Cited by 77
Wachtel, M., Bolliger, M. F., Ishihara, H., Frei, K., Bluethmann, H., & Gloor, S. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00399.x · Cited by 76
Production of MMPs in Human Cerebral Endothelial Cells and Their Role in Shedding Adhesion Molecules
Hummel, V., Kallmann, B. A., Wagner, S., Fuller, T., Bayas, A., Tonn, J.-C., Benveniste, E. N., Toyka, K. V., & Rieckmann, P. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.4.320 · Cited by 76
Nygårdas, P., & Hinkkanen, A. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01855.x · Cited by 73
IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier
Linker, R. A., Lühder, F., Kallen, K., Lee, D.-H., Engelhardt, B., Rose‐John, S., & Gold, R. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.007 · Cited by 73
Krakauer, M., Sørensen, P. S., Khademi, M., Olsson, T. P., & Sellebjerg, F. T. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458507087136 · Cited by 73
Seabrook, T. J., Littlewood-Evans, A., Brinkmann, V., Pöllinger, B., Schnell, C., & HIESTAND, P. C. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-95 · Cited by 73
Lombardi, A., Cantini, G., Piscitelli, E., Gelmini, S., Francalanci, M., Mello, T., Ceni, E., Varano, G., Forti, G., Rotondi, M., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.160713 · Cited by 71
Alexander, J. S., Harris, M., Wells, S., Mills, G. M., Chalamidas, K., Ganta, V. C., McGee, J. C., Jennings, M. H., Gonzalez-Toledo, E., & Minagar, A. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510370791 · Cited by 71
Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease
Monteleone, G., Pallone, F., & MacDonald, T. T. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.02.002 · Cited by 71
Selective localisation of neuro-specific T lymphocytes in the central nervous system
Ludowyk, P. A., Willenborg, D. O., & Parish, C. R. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90008-9 · Cited by 70
Suidan, G. L., Dickerson, J. W., Chen, Y., Mcdole, J. R., Tripathi, P., Pirko, I., Seroogy, K. B., & Johnson, A. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902773 · Cited by 69
RGMA and IL21R show association with experimental inflammation and multiple sclerosis
Nohra, R. G., Beyeen, A. D., Guo, J. P., Khademi, M., Sundqvist, E., Hedreul, M. T., Sellebjerg, F. T., Smestad, C., Oturai, A. B., Harbo, H. F., et al. (2010) · Genes and Immunity · doi:10.1038/gene.2009.111 · Cited by 66
Bluyssen, H. A. R., Rastmanesh, M. M., Tilburgs, C., Jie, K. E., Wesseling, S., Goumans, M., de Boer, P., Joles, J. A., & Braam, B. G. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00513.2009 · Cited by 66
Ultrastructure of the blood-brain barrier in the rabbit.
Sedlakova, R., Shivers, R. R., & Maestro, R. F. D. (1999) · PubMed · Cited by 66
Pathophysiological role of calpain in experimental demyelination
Shields, D. C., & Banik, N. L. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990301)55:5 · Cited by 64
Matrix metalloproteinase‐19 is highly expressed in active multiple sclerosis lesions
van Horssen, J., Vos, C. M. P., Admiraal, L., van Haastert, E. S., Montagne, L., van der Valk, P., & de Vries, H. E. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00766.x · Cited by 64
Angiostatic activity of the antitumor cytokine interleukin-21
Castermans, K., Tabruyn, S. P., Zeng, R., B, J. R. V. B., Eppolito, C., Leonard, W. J., Shrikant, P. A., & Griffioen, A. W. (2008) · Blood · doi:10.1182/blood-2007-09-113878 · Cited by 64
Piao, W., Jee, Y., Liu, R. L., Coons, S. W., Kala, M., Collins, M. A., Young, D. A., Campagnolo, D. I., Vollmer, T. L., Bai, X., et al. (2007) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.02035.x · Cited by 63
FOXO1 plays an essential role in apoptosis of retinal pericytes.
Alikhani, M., Roy, S., & Graves, D. T. (2010) · PubMed Central · Cited by 63
Metalloproteinases and their Tissue Inhibitors in Multiple Sclerosis
Özenci, V., Rinaldi, L., Teleshova, N., Matusevičius, D., Kivisäkk, P., Kouwenhoven, M. C. M., & Link, H. (1999) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0285 · Cited by 62
Hoffmann, O. M., Zipp, F., & Weber, J. R. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0484-x · Cited by 62
Rattan, V., Sultana, C., Shen, Y. M., & Kalra, V. K. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.3.e453 · Cited by 62
Frisullo, G., Nociti, V., Iorio, R., Patanella, A. K., Marti, A., Caggiula, M., Massimiliano Mirabella, A., Tonali, P. A., & Batocchi, A. P. (2008) · Cytokine · doi:10.1016/j.cyto.2008.08.007 · Cited by 61
Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis
Alonso, Á., Jick, S. S., & Hernán, M. Á. (2006) · Neurology · doi:10.1212/01.wnl.0000198507.13597.45 · Cited by 60
Astrocytes in the tempest of multiple sclerosis
Miljković, D. M., Timotijević, G. S., & Stojković, M. M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.047 · Cited by 60
Granzyme B mediates neurotoxicity through a G‐protein‐coupled receptor
Wang, T.-G., Allie, R., Conant, K., Haughey, N., Turchan-Cholewo, J., Hahn, K., Rosen, A., Steiner, J., Keswani, S., Jones, M. V., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5022fje · Cited by 60
Free oxygen radicals decrease electrical resistance of microvascular endothelium in brain
Olesen, S. (1987) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1987.tb08057.x · Cited by 59
Opening of the blood-brain barrier during cortical superfusion with histamine
Schilling, L., & Wahl, M. (1994) · Brain Research · doi:10.1016/0006-8993(94)90403-0 · Cited by 58
Activated T-cells inhibit neurogenesis by releasing granzyme B: rescue by Kv1.3 blockers
Wang, T., Lee, M.-H., Johnson, T., Allie, R., Hu, L., Calabresi, P. A., & Nath, A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0311-10.2010 · Cited by 58
Lu, C., Diehl, S. A., Noubade, R., Ledoux, J., Nelson, M. T., Spach, K. M., Zachary, J. F., Blankenhorn, E. P., & Teuscher, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008816107 · Cited by 58
IL‐27 inhibits OSM‐mediated TNF‐α and iNOS gene expression in microglia
Baker, B. J., Park, K. W., Qin, H., Ma, X., & Benveniste, E. N. (2010) · Glia · doi:10.1002/glia.20989 · Cited by 57
Imaizumi, S., Kondo, T., Deli, M. A., Gobbel, G. T., Joó, F., Epstein, C. J., Yoshimoto, T., & Chan, P. H. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00120-4 · Cited by 53
Expression of IFN-gamma in Cerebrovascular Endothelial Cells from Aged Mice
Wei, Y., Kita, M., Shinmura, K., Yan, X.-Q., Fukuyama, R., Fushiki, S., & Imanishi, J. (2000) · Journal of Interferon & Cytokine Research · doi:10.1089/107999000312342 · Cited by 52
Ensoli, F., Valeria Fiorelli, A., DeCristofaro, M., Muratori, D. S., Novi, A., Vannelli, B., Thiele, C. J., Luzi, G., & Aiuti, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.6268 · Cited by 51
SHARMA, H. S. (2003) · Springer eBooks · doi:10.1007/978-3-7091-0651-8_81 · Cited by 50
Tsuge, M., Yasui, K., Ichiyawa, T., Saito, Y., Nagaoka, Y., Yashiro, M., Yamashita, N., & Morishima, T. (2010) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2010.00226.x · Cited by 49
Differential expression of interferon-γ receptor on human glial cells in vivo and in vitro
Hashioka, S., Klegeris, A., Schwab, C., Yu, S. Y., & McGeer, P. L. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.04.023 · Cited by 48
Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo
Weiss, T. W., Samson, A. L., Niego, B., Daniel, P. B., & Medcalf, R. L. (2006) · The FASEB Journal · doi:10.1096/fj.06-5850fje · Cited by 48
A Pilot, Open Label, Clinical Trial Using Hydroxyzine in Multiple Sclerosis
Logothetis, I., Mylonas, I. A., Baloyannis, S., Pashalidou, M., Orologas, A., Ζαφειρόπουλος, Α., Kosta, V., & Theoharides, T. C. (2005) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200501800421 · Cited by 48
Lee, H., Kim, H. J., Kim, J., & Chang, N. (2003) · Brain Research · doi:10.1016/j.brainres.2003.10.027 · Cited by 47
Copray, S. C. V. M., Küst, B., Emmer, B. J., Lin, M. Y., Liem, R. S. B., Amor, S., de Vries, H. E., Floris, S., & Boddeke, E. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.11.008 · Cited by 46
Micera, A., Properzi, G., Triaca, V., & Aloe, L. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00272-6 · Cited by 45
Millward, J. M., Løbner, M., Wheeler, R. D., & Owens, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902153 · Cited by 44
Kikuchi, S., Miyagishi, R., Fukazawa, T., Yabe, I., Miyazaki, Y., & Sasaki, H. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.06.021 · Cited by 44
Sultan, S., Gosling, M., Nagase, H., & Powell, J. T. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00337-0 · Cited by 43
Biernacki, K., Prat, A., Blain, M., & Antel, J. (2004) · Journal of Neuropathology and Experimental Neurology · doi:10.1093/jnen/63.3.223 · Cited by 43
Self-citationGlezer, I., & Rivest, S. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.01.005 · Cited by 42
Hashioka, S., Klegeris, A., Qing, H., & McGeer, P. L. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.018 · Cited by 41
Death receptor expression and function at the human blood brain barrier
Wosik, K., Biernacki, K., Khouzam, M.-P., & Prat, A. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.08.018 · Cited by 41
Self-citationLiu, R., Bai, Y., Vollmer, T. L., Bai, X., Jee, Y., Tang, Y., Campagnolo, D. I., Collins, M. A., Young, D. A., Cava, A. L., et al. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.004 · Cited by 41
Thorne, M., Moore, C. S., & Robertson, G. S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.04.003 · Cited by 40
Alvarez, J. I., & Teale, J. M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.036 · Cited by 39
Self-citationRyu, H. J., Kim, J.-E., Kim, M.-J., Kwon, H., Suh, S. W., Song, H., & Kang, T. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.07.048 · Cited by 37
Human NK Cells Lyse Organ-Specific Endothelial Cells: Analysis of Adhesion and Cytotoxic Mechanisms
Bielawska‐Pohl, A., Silva, C. C. D., Caignard, A., Gaudin, C., Duś, D., Kiéda, C., & Chouaı̈b, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5573 · Cited by 37
Moidunny, S., Dias, R. B., Wesseling, E. M., Sekino, Y., Boddeke, H. W. G. M., Sebastião, A. M., & Biber, K. P. H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06881.x · Cited by 36
Kahl, K. G., Kruse, N., Toyka, K. V., & Rieckmann, P. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00136-3 · Cited by 34
Takata, F., Sumi, N., Nishioku, T., Harada, E., Wakigawa, T., Shuto, H., Yamauchi, A., & Kataoka, Y. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.030 · Cited by 34
Apoptosis-related molecules in blood in multiple sclerosis
Hagman, S., Kuusisto, H., Raunio, M., Paalavuo, R., Levula, M., Lehtimäki, T. J., & Elovaara, I. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.002 · Cited by 32
Lombardi, A., Cantini, G., Mello, T., Francalanci, M., Gelmini, S., Cosmi, L., Santarlasci, V., Degl’Innocenti, S., Luciani, P., Deledda, C., et al. (2009) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2009.07.004 · Cited by 30
Evidence for the involvement of histamine in the regulation of blood-brain barrier permeability
Gulati, A., Dhawan, K. N., Shukla, R., Srimal, R. C., & Dhawan, B. N. (1985) · Pharmacological Research Communications · doi:10.1016/0031-6989(85)90019-0 · Cited by 30
Ensoli, F., Valeria Fiorelli, A., Lugaresi, A., Farina, D., Cristofaro, M. D., Collacchi, B., Muratori, D. S., Scala, E., Gioacchino, M. D., Paganelli, R., et al. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms817oa · Cited by 30
Microglia express a functional receptor for interleukin-23
Sonobe, Y., Liang, J., Jin, S., Zhang, G., Takeuchi, H., Mizuno, T., & Suzumura, A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.059 · Cited by 29
van Boxel-Dezaire, A. H. H., Smits, M., Trigt-Hoff, S. C. J. V., Killestein, J., van Houwelingen, H. C., Polman, C. H., & Nagelkerken, L. M. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00398-8 · Cited by 29
Krüger, K., Büning, C., & Schriever, F. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200101)31:1 · Cited by 27
Althoff, G. E. M., Wolfer, D. P., Timmesfeld, N., Kanzler, B., Schrewe, H., & Pagenstecher, A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090918 · Cited by 27
Lapilla, M., Gallo, B. M., Martinello, M., Procaccini, C., Costanza, M., Musio, S., Rossi, B., Angiari, S., Farina, C., Steinman, L., et al. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0910486 · Cited by 27
Doerck, S., Göbel, K., Weise, G., Schneider‐Hohendorf, T., Reinhardt, M., Hauff, P., Schwab, N., Linker, R. A., Mäurer, M., Meuth, S. G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015478 · Cited by 27
Patnaik, R., Mohanty, S., & Sharma, H. S. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6346-7_112 · Cited by 26
Cited by
Sorted by citations
Daneman, R., & Prat, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020412 · Cited by 3,437
Self-citationPeripheral inflammation and blood–brain barrier disruption: effects and mechanisms
Huang, X., Hussain, B., & Chang, J. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13569 · Cited by 759
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
The dynamic blood–brain barrier
Keaney, J., & Campbell, M. (2015) · The FEBS Journal · doi:10.1111/febs.13412 · Cited by 616
The impact of microglial activation on blood-brain barrier in brain diseases
da Fonseca, A. C. C., Matias, D., Garcia, C., Amaral, R., Geraldo, L. H., Freitas, C., & Lima, F. R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00362 · Cited by 572
Metadata
- Authors
- Larochelle, C., Alvarez, J. I., & Prat, A.
- Affiliations
- Hôpital Notre-Dame (CA)
- Corresponding author
- Prat, Alexandre
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2011-05-04
- Volume
- 585
- Issue
- 23
- Pages
- 3770-3780
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2007217012
- Cited by
- 405
- References
- 222
- Citations by year
- 2026: 15 · 2025: 26 · 2024: 36 · 2023: 32 · 2022: 26 · 2021: 39 · 2020: 31 · 2019: 26 · 2018: 27 · 2017: 25 · 2016: 38 · 2015: 25 · 2014: 23 · 2013: 18 · 2012: 16
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- FEBS Letters (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Multiple Sclerosis Society of Canada
- Multiple Sclerosis Society
- Canadian Institutes of Health Research (MOP89885, MOP14828)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- multiple sclerosis, blood-brain barrier, leukocyte migration, immune cell infiltration, blood-brain barrier permeability, reactive oxygen species, inflammatory cytokines, neuroinflammation, BBB dysfunction
- MeSH terms
- Animals, Blood-Brain Barrier, Cell Movement, Humans, Lymphocytes, Multiple Sclerosis, Reactive Oxygen Species, Matrix Metalloproteinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review